These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


293 related items for PubMed ID: 9815555

  • 1. Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.
    Lawrence JB, Conover CA, Haddad TC, Ingle JN, Reid JM, Ames MM, Suman VJ, Marks RS, Erlichman C, Hartmann LC.
    Clin Cancer Res; 1997 Oct; 3(10):1713-20. PubMed ID: 9815555
    [Abstract] [Full Text] [Related]

  • 2. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR.
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202
    [Abstract] [Full Text] [Related]

  • 3. Effects of tamoxifen on insulin-like growth factors, IGF binding proteins and IGFBP-3 proteolysis in breast cancer patients.
    Grønbaek H, Tanos V, Meirow D, Peretz T, Raz I, Flyvbjerg A.
    Anticancer Res; 2003 Aug; 23(3C):2815-20. PubMed ID: 12926118
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF, Hsing AW.
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
    [Abstract] [Full Text] [Related]

  • 5. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A.
    Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
    [Abstract] [Full Text] [Related]

  • 6. The changes of IGF binding proteins after rhGH administration to patients totally dependent on parenteral nutrition.
    Justová V, Lacinová Z, Melenovský V, Marek J, Holly JM, Hass T.
    Growth Horm IGF Res; 2001 Dec; 11(6):407-15. PubMed ID: 11914029
    [Abstract] [Full Text] [Related]

  • 7. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
    Decensi A, Veronesi U, Miceli R, Johansson H, Mariani L, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Costa A, Perloff M, Malone WF, Formelli F.
    Clin Cancer Res; 2003 Oct 15; 9(13):4722-9. PubMed ID: 14581342
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factors and their binding proteins in children with IDDM.
    Wacharasindhu S, Srivuthana S, Aroonparkmongkol S.
    J Med Assoc Thai; 2002 Jan 15; 85(1):41-52. PubMed ID: 12075719
    [Abstract] [Full Text] [Related]

  • 9. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E, Köksal D, Yurdakul AS, Atikcan S, Cinaz P.
    Respir Med; 2005 May 15; 99(5):559-65. PubMed ID: 15823452
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY, Choi BG, Choi JY, Lee SY, Ju SY.
    Lung Cancer; 2006 Nov 15; 54(2):227-34. PubMed ID: 16935391
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.
    Grønbaek H, Flyvbjerg A, Mellemkjaer L, Tjønneland A, Christensen J, Sørensen HT, Overvad K.
    Cancer Epidemiol Biomarkers Prev; 2004 Nov 15; 13(11 Pt 1):1759-64. PubMed ID: 15533904
    [Abstract] [Full Text] [Related]

  • 14. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, Keinan-Boker L, van Gils CH, Peeters PH.
    Cancer Causes Control; 2004 Oct 15; 15(8):787-96. PubMed ID: 15456992
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factors and breast cancer risk in Chinese women.
    Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2002 Aug 15; 11(8):705-12. PubMed ID: 12163322
    [Abstract] [Full Text] [Related]

  • 16. Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease.
    Fischer F, Schulte H, Mohan S, Tataru MC, Köhler E, Assmann G, von Eckardstein A.
    Clin Endocrinol (Oxf); 2004 Nov 15; 61(5):595-602. PubMed ID: 15521962
    [Abstract] [Full Text] [Related]

  • 17. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
    Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH.
    Cancer Epidemiol Biomarkers Prev; 2004 May 15; 13(5):748-52. PubMed ID: 15159305
    [Abstract] [Full Text] [Related]

  • 18. The IGF system in the neonatal ovine uterus.
    Hayashi K, Carpenter KD, Welsh TH, Burghardt RC, Spicer LJ, Spencer TE.
    Reproduction; 2005 Mar 15; 129(3):337-47. PubMed ID: 15749960
    [Abstract] [Full Text] [Related]

  • 19. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Boillot C, Rinaldi S, Llewellyn M, Chajès V, Clavel-Chapelon F, Téhard B, Chang-Claude J, Linseisen J, Lahmann PH, Pischon T, Trichopoulos D, Trichopoulou A, Zilis D, Palli D, Tumino R, Vineis P, Berrino F, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Pera G, Barricarte A, Chirlaque MD, Quirós JR, Larrañaga N, Martínez-García C, Allen NE, Key TJ, Bingham SA, Khaw KT, Slimani N, Norat T, Riboli E, Kaaks R.
    Cancer Epidemiol Biomarkers Prev; 2005 Oct 15; 14(10):2316-25. PubMed ID: 16214911
    [Abstract] [Full Text] [Related]

  • 20. Suramin and serum insulin-like growth factor levels in metastatic cancer patients.
    Miglietta L, Barreca A, Repetto L, Costantini M, Rosso R, Boccardo F.
    Anticancer Res; 1993 Oct 15; 13(6B):2473-6. PubMed ID: 8135485
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.